Greetings,

An IFCN sponsored committee has prepared the 3rd edition of, “Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues.” The documents Safety and recommendations for TMS and Supplemental materials are now in draft form and we welcome public comment that will help in finalizing the document. Please send your comments to crussell@ifcn.info by April 13. Feel free to share this opportunity with your colleagues. The final manuscript will be published in Clinical Neurophysiology.

Thank you for your assistance,

Clarissa L Russell
Executive Director of
International Federation of Clinical Neurophysiology (IFCN)
11190 Sunrise Valley Drive, Suite 300
Reston, VA 20191
703.438.3103
crussell@aim-hq.com